R. Donald HarveyConsulting or Advisory Role: Bristol Myers Squibb/MedarexResearch Funding: AstraZeneca (Inst), Calithera Biosciences (Inst), Pfizer (Inst), AbbVie (Inst), Genmab (Inst), Nektar (Inst), Rgenix (Inst), Xencor (Inst), Meryx Pharmaceuticals (Inst), Abbisko (Inst), Actuate Therapeutics (Inst), Alkermes (Inst), Amgen (Inst), Bayer (Inst), Fujifilm (Inst), GlaxoSmithKline (Inst), Infinity Pharmaceuticals (Inst), Inhibrx (Inst), Merck (Inst), Mersana (Inst), Puma Biotechnology (Inst), RAPT Therapeutics (Inst), Seattle Genetics (Inst), Sutro Biopharma (Inst), Takeda (Inst)No other potential conflicts of interest were reported.